Literature DB >> 16455151

HBV drug resistance: mechanisms, detection and interpretation.

Tim Shaw1, Angeline Bartholomeusz, Stephen Locarnini.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16455151     DOI： 10.1016/j.jhep.2006.01.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  64 in total

1.  Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids.

Authors:  Shuhei Hige; Yoichi Yamamoto; Shigeru Yoshida; Tomoe Kobayashi; Hiromasa Horimoto; Keiko Yamamoto; Takuya Sho; Mitsuteru Natsuizaka; Mitsuru Nakanishi; Makoto Chuma; Masahiro Asaka
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Therapeutic implications of hepatitis C virus resistance to antiviral drugs.

Authors:  Jean-Michel Pawlotsky
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

3.  Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains.

Authors:  Yun Bin Lee; Jeong-Hoon Lee; Dong Hyeon Lee; Hyeki Cho; Hongkeun Ahn; Won-Mook Choi; Young Youn Cho; Minjong Lee; Jeong-Ju Yoo; Yuri Cho; Eun Ju Cho; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon; Chung Yong Kim; Hyo-Suk Lee
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 4.  Antiviral therapies: focus on hepatitis B reverse transcriptase.

Authors:  Eleftherios Michailidis; Karen A Kirby; Atsuko Hachiya; Wangdon Yoo; Sun Pyo Hong; Soo-Ok Kim; William R Folk; Stefan G Sarafianos
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

5.  Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.

Authors:  Soo-Yon Rhee; Severine Margeridon-Thermet; Mindie H Nguyen; Tommy F Liu; Ron M Kagan; Bastian Beggel; Jens Verheyen; Rolf Kaiser; Robert W Shafer
Journal:  Antiviral Res       Date:  2010-09-25       Impact factor: 5.970

6.  Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.

Authors:  Catherine W Cai; Elena Lomonosova; Eileen A Moran; Xiaohong Cheng; Kunjan B Patel; Fabrice Bailly; Philippe Cotelle; Marvin J Meyers; John E Tavis
Journal:  Antiviral Res       Date:  2014-05-20       Impact factor: 5.970

7.  Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.

Authors:  Robert P Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; Nancy Leung; William M Lee; Susan Dixon; Mary Woessner; Carol L Brosgart; Lynn D Condreay; Stephen D Gardner
Journal:  Hepatol Int       Date:  2011-01-05       Impact factor: 6.047

8.  Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.

Authors:  Hyunjung Jang; Jihyun Kim; Jae-jin Choi; Yeojin Son; Heekyung Park
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

9.  Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.

Authors:  Debika Bhattacharya; Martha J Lewis; Britta Lassmann; Tina Phan; Gaby Knecht; Marcus Bickel; Otto O Yang
Journal:  J Virol Methods       Date:  2013-02-28       Impact factor: 2.014

Review 10.  Current treatment indications and strategies in chronic hepatitis B virus infection.

Authors:  George V Papatheodoridis; Spilios Manolakopoulos; Athanasios J Archimandritis
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.